Document is current
Any future updates will be listed below
-
Authors
Widjaja, Liam https://orcid.org/0000-0002-0243-9338
Siegmund, Sophie C.
Gildehaus, Franz J.
Schmidt-Hegemann, Nina-Sophie
Pomper, Martin G.
Rowe, Steven P.
Bundschuh, Ralph A.
Wenter, Vera
Sheikh, Gabriel T.
Klimek, Konrad
Stief, Christian G.
Zacherl, Mathias J.
Werner, Rudolf A.
Casuscelli, Jozefina
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 18 September 2025
Accepted: 21 January 2026
First Online: 9 February 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the ethical committee of Ludwig-Maximilians University (#25–0130).
: All participants consented to imaging and subsequent therapy, as well as to potential scientific analysis.
: RAW has received speaker honoraria from Novartis/AAA and PentixaPharm, reports advisory board work for Novartis/AAA and Bayer.RAB is Consultant for and has received speaker´s honoraria from Bayer Healthcare (Leverkusen, Germany), Novartis (Nürnberg, Germany), Terumo GmbH (Eschborn, Germany), and Eisai GmbH (Frankfurt, Germany) and has received travel expenses from Blue Earth Therapeutics (Oxford, UK).JC has received speaker honoraria, travel expenses and reports advisory board work from Astellas, Astra Zeneca, Bayer, BMS, Eisai, Ipsen, Johnson&Johnson, Merck, MSD, and Novartis.
